Andrés Esteban-Cantos

Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial

Andrés Esteban-Cantos, Javier Rodríguez-Centeno, Pilar Barrúz et al. · The Lancet HIV · 2021 · 105 citations

Medicine, Immunology, Aging +12

Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years

Isabella C Schoepf, Andrés Esteban-Cantos, Christian Thorball et al. · The Lancet Healthy Longevity · 2023 · 50 citations · Full text

Public Health, Immunology, Aging +14

Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea)

Pedro Berzosa, Andrés Esteban-Cantos, Luz García et al. · Malaria Journal · 2017 · 48 citations · Full text

Medicine, Pharmacology, Molecular Epidemiology +16

Longitudinal Changes in Epigenetic Age Acceleration in Aviremic Human Immunodeficiency Virus–Infected Recipients of Long-term Antiretroviral Treatment

Andrés Esteban-Cantos, Rocío Montejano, Javier Rodríguez-Centeno et al. · The Journal of Infectious Diseases · 2021 · 44 citations

Life Sciences, Immunology, Molecular Biology +14

Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)

Rosa de Miguel Buckley, David Rial‐Crestelo, Lourdes Domínguez et al. · EBioMedicine · 2020 · 37 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17